Richard Urquhart

Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients

Denis Delić, Claudia Eisele, Ramona Schmid et al. · PLoS ONE · 2016 · 226 citations · Full text

Pathology, Extracellular Microvesicles, Type Ii Diabetes +19

Long-term efficacy and tolerability of add-on pioglitazone therapy to failing monotherapy compared with addition of gliclazide or metformin in patients with type 2 diabetes

B Charbonnel, Guntram Schernthaner, P. Brunetti et al. · Diabetologia · 2005 · 170 citations · Full text

Diabetes Management, Long-term Efficacy, Diabetes +6

A Mechanism-based Disease Progression Model for Comparison of Long-term Effects of Pioglitazone, Metformin and Gliclazide on Disease Processes Underlying Type 2 Diabetes Mellitus

Willem de Winter, Joost DeJongh, Teun M. Post et al. · Journal of Pharmacokinetics and Pharmacodynamics · 2006 · 146 citations

Metabolic Syndrome, Diabetes Management, Long-term Effects +5

Comparison of Pioglitazone and Gliclazide in Sustaining Glycemic Control Over 2 Years in Patients With Type 2 Diabetes

Meng H. Tan, A. John Baksi, B Krahulec et al. · Diabetes Care · 2005 · 109 citations · Full text

Safety and tolerability of pioglitazone, metformin, and gliclazide in the treatment of type 2 diabetes

G Belcher, Ceri Lambert, Gareth Edwards et al. · Diabetes Research and Clinical Practice · 2005 · 89 citations

Diabetes Management, Insulin Management, Diabetes +5